SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION Russian patent published in 2013 - IPC C07K16/28 C07K16/46 C12N15/13 C12N15/63 A61K39/395 A61P35/00 A61P37/00 

Abstract RU 2487888 C2

FIELD: chemistry.

SUBSTANCE: disclosed is a single-chain multi-specific binding protein for binding or modulating activity of one or more biding partner molecules. The protein contains from the N-terminal to the C-terminal: a first binding domain derived from variable regions of a light and a heavy immunoglobulin chain; a constant sub-region derived from immunoglobulin containing a hinge or hinge-like domain, a CH2-domain and a CH3-domain; scorpion linker peptide, where said peptide contains an amino acid sequence from the immunoglobulin hinge or a type II C-lectin protein stalk region; and a second binding domain derived from variable regions of a light and a heavy immunoglobulin chain. The invention describes an encoding nucleic acid, as well as an expression vector based thereon and a host cell for vector based protein expression. The invention discloses a pharmaceutical composition for treating cell proliferation disorders based on a single-chain protein and a protein dimer for binding or modulating activity of one or more binding partner molecules based on two single-chain binding proteins.

EFFECT: invention provides multi-specific molecules which retain effector functions, insensitivity to proteolytic cleavage, and can be used in therapy of different diseases.

31 cl, 61 dwg, 14 tbl, 19 ex

Similar patents RU2487888C2

Title Year Author Number
CD37-IMMUNOTHERAPEUTIC COMBINATION THERAPY AND USING IT 2009
  • Kerveni Charl'Z G.
  • Tompson Piter A.
RU2526156C2
IMMUNOTHERAPY OF MALIGNANT DISEASES OF B-CELLS AND AUTOIMMUNE DISEASES WITH APPLICATION OF CONJUGATE AND NONCONJUGATE ANTIBODIES, COMBINATIONS OF ANTIBODIES AND CONJOINT PROTEINS 2003
  • Goldenberg Dehvid M.
  • Khansen Khans
RU2335297C2
MOLECULES WITH SPECIFICITY WITH RESPECT TO CD79 AND CD22 2015
  • Finni Khelen Margaret
  • Rejpetski Stefen Edvard
  • Rajt Majkl Dzhon
  • Tajson Kerri
RU2743590C2
DECREASING B-CELL COUNT WITH USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES 2006
  • Grosmehjr Laura S'Ju
  • Khajdehn-Ledbehttehr Marta S'Juzan
  • Ledbehttehr Dzheffri A.
  • Tompson Piter Armstrong
  • Sajmon Sandi Aleksander
  • Brehdi Uill'Jam
RU2423381C2
PROTEINS BINDING SPECIFIC MEMBRANE PROSTATE ANTIGEN, AND RELATED COMPOSITIONS AND METHODS 2012
  • Blankenship Dzhon V.
  • Sevell Elejn Todd
  • Tan Filip
RU2632647C2
IMMUNOGLOBULIN WITH DOUBLE VARIABLE DOMAINS AND ITS APPLICATIONS 2006
  • Vu Chenbin
  • Gkhajur Tarik
  • Dikson Richard V
  • Zal'Fel'D Jokhen G
RU2515108C2
POLYPEPTIDES BINDING TO CD3 2013
  • Tan Filip Khuat
  • Nataradzhan Satish Kumar
  • Makmakhan Ketrin Dzh.
RU2673153C2
COMBINED THERAPY FOR TREATMENT OF AUTOIMMUNE DISEASES BY USING COMBINATION OF ELIMINATING B-CELLS AND IMMUNOREGULATORY ANTIBODIES 2001
  • Khanna Nabil
RU2285541C2
BISPECIFIC ASYMMETRIC HETERODIMERS COMPRISING ANTI-CD3 CONSTRUCTS 2013
  • Dixit Surjit Bhimarao
  • Spreter Von Kreudenstein Thomas
  • Ng Gordon Yiu Kon
  • Weisser Nina E.
RU2650868C2
IMMUNOTHERAPEUTIC AGENT COMBINED WITH CD37, AND ITS COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC AGENT 2009
  • Tan,Filip
  • Sajmon,Sandi,Aleksander
  • Kerveni,Charl'Z,G.
  • Nilsson,Kristi,Ehnn
  • Brehdi,Uill'Jam
  • Ledbehttehr,Dzheffri,A.
  • Khajdehn-Ledbehttehr,Marta,S'Juzan
  • Tompson,Piter,Armstrong
  • Morales,Sesil'
RU2531754C2

RU 2 487 888 C2

Authors

Tompson Piter Armstrong

Ledbehttehr Dzheffri A.

Khajdehn-Ledbehttehr Marta S'Juzan

Grosmehjr Laura S'Ju

Bader Robert

Brehdi Uill'Jam

Chistjakova Ljudmila

Folletti Maksimillian T.

Kalabro Valeri

Shuler Aluin

Dates

2013-07-20Published

2007-06-12Filed